Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 44: 1430-1436, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hetland, O.
Right arrow Articles by Dickstein, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hetland, O.
Right arrow Articles by Dickstein, K.
Related Collections
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1998;44:1430-1436.)
© 1998 American Association for Clinical Chemistry, Inc.


Enzymes and Protein Markers

Cardiac troponins I and T in patients with suspected acute coronary syndrome: a comparative study in a routine setting

Øyvind Hetland1,a, and Kenneth Dickstein2

Departments of
1 Clinical Chemistry and
2 Medicine, Section for Cardiology, Rogaland Central Hospital, 4011 Stavanger, Norway.
a Author for correspondence. Fax 47-51519907.

We compared cardiac troponin I (cTnI), using Access®, Sanofi Pasteur, and cardiac troponin T (cTnT), using Elecsys®, Boehringer Mannheim, in the first two routine blood samplings in a routine panel of cardiac markers for the biochemical diagnostic evaluation of patients with symptoms of acute myocardial infarction (AMI). No significant differences in the overall clinical performances of cTnI and cTnT were observed for the diagnosis of AMI (n = 68), but cTnI demonstrated lower initial sensitivity and higher specificity compared with cTnT. cTnT was increased to higher relative values than cTnI (P = 0.023). Discordances were found between cTnI and cTnT in sample I but not in sample II; positive cTnT/negative cTnI was more common than the opposite discordance (P = 0.027). cTnT was more frequently increased in patients with unstable angina pectoris (UAP) than cTnI (P = 0.038), with no significant differences between sample I and sample II; discordant results with respect to cTnI and cTnT appeared in 6 (33%) of these patients, all of which were positive for cTnT and negative for cTnI. Four patients with UAP (22%) developed AMI within 4 months; three were associated with increased cTnI and cTnT at the time of initial testing, and one was discordant (positive cTnT). In patients classified with no acute coronary syndrome (n = 84), five concordant positives for cTnI and cTnT were observed, indicating the existence of a myocardial injury of recent origin in these patients. AMI evolved in one of these patients 5 months later. We conclude that cTnT and cTnI detect acute myocardial injury with equal clinical performance in AMI patients classified by WHO criteria. cTnT was more frequently increased in patients with UAP than cTnI, but the clinical significance of this discordance could not be determined from this study.




The following articles in journals at HighWire Press have cited this article:


Home page
ANGIOLOGYHome page
M. Rajappa and A. Sharma
Biomarkers of Cardiac Injury: An Update
Angiology, November 1, 2005; 56(6): 677 - 691.
[Abstract] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
S Clark, P Newland, C W Yoxall, and N V Subhedar
Concentrations of cardiac troponin T in neonates with and without respiratory distress
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2004; 89(4): F348 - F352.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. D. Douketis, M. A. Crowther, E. B. Stanton, and J. S. Ginsberg
Elevated Cardiac Troponin Levels in Patients With Submassive Pulmonary Embolism
Arch Intern Med, January 14, 2002; 162(1): 79 - 81.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
S J MAYNARD, I B A MENOWN, and A A J ADGEY
Troponin T or troponin I as cardiac markers in ischaemic heart disease
Heart, April 1, 2000; 83(4): 371 - 373.
[Full Text]


Home page
Clin. Chem.Home page
C. Heeschen, B. U. Goldmann, L. Langenbrink, G. Matschuck, and C. W. Hamm
Evaluation of a Rapid Whole Blood ELISA for Quantification of Troponin I in Patients with Acute Chest Pain
Clin. Chem., October 1, 1999; 45(10): 1789 - 1796.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.